Chinanews.com, Beijing, August 26 (Reporter Zhang Su) Will polycystic ovary syndrome get better?

The reporter learned from the China Red Cross Foundation on the 26th that in order to answer patients’ questions, the eighth "Female androgenism" publicity day event of "Enabling Her Strength-China Gynecology Development Public Welfare Project" invited gynecologists to speak.

　　"Polycystic ovary syndrome is a common endocrine disease among Chinese women. Effective communication with patients with polycystic ovary syndrome who come to see a doctor is essential for patients to cooperate with long-term standard treatment." said Wu Yinglan, a professor at Hunan Maternity and Child Health Hospital.

　　According to reports, polycystic ovary syndrome is a common endocrine and metabolic disease caused by genetic and environmental factors.

Common clinical manifestations include menstrual abnormalities, infertility, hyperandrogenism, etc., which can be accompanied by metabolic abnormalities such as obesity, insulin resistance, and dyslipidemia. They are high-risk factors for type 2 diabetes, cardiovascular disease, and endometrial cancer.

　　Wu Yinglan recommends the "Three Steps of Communication for Patients with Polycystic Ovary Syndrome".

First, explain to patients what polycystic ovary syndrome is, and its clinical manifestations and diagnostic basis; next, it is necessary to emphasize that polycystic ovary syndrome has a long-term and extensive impact on women's health so that patients can accept and cooperate with management.

　　"Finally, it should be emphasized that polycystic ovary syndrome is a disease that requires long-term management. Using the first-line short-acting oral contraceptives recommended by the guidelines can effectively improve symptoms, increase fertility, and prevent long-term harm." She said.

　　In order to promote the development of China's gynecological diagnosis and treatment level, in 2019, the China Red Cross Foundation and Bayer Healthcare Co., Ltd. jointly launched the "Engage Her Strength-China Gynecology Development Public Welfare Project".

The project invites well-known domestic experts to explain and share the diagnosis and treatment of gynecological endocrinology, and guide clinicians to diagnose and treat patients more accurately, quickly and efficiently in actual diagnosis and treatment.

　　Beginning in 2021, the "Engage Her Strength-China Gynecology Development Public Welfare Project" will launch the "Female Hyperandrogenism" publicity day on the 28th of each month.

According to the arrangement, Wu Yinglan will take "Doctor-patient communication: Will it be okay to have polycystic ovary syndrome?" on August 28, focusing on explaining the three steps of communication for patients with polycystic ovary syndrome, including communication with polycystic ovary syndrome. Hazards, diagnosis, treatment and long-term management.

(over)